Top-News
Professionelle Dienstleistungen Schweiz

Kinarus Therapeutics News

Aktie
WKN:  928449 ISIN:  CH0009115129
0,0036 CHF
-0,0002 CHF
-5,26%
25.04.24 17:10:45
Handeln Depot/Watchlist
Aktienanzahl *
1,30 Mrd.
Marktkapitalisierung *
4,74 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 11.03.2024

Kinarus Therapeutics News

26.04.24 - DGAP
Business Combination of Kinarus Therapeutics Holding AG (now renamed to Curatis Holding AG) and Curatis AG completed
Kinarus Therapeutics Holding AG / Key word(s): Acquisition/Corporate Action Business Combination of Kinarus Therapeutics Holding AG (now renamed to Curatis Holding AG) and ...
17.04.24 - DGAP
Kinarus Therapeutics Holding AG publishes FY2023 Financial Statements and announces details on Business Combination with Curatis AG and Reverse Share Split
Kinarus Therapeutics Holding AG / Key word(s): Annual Results/Capital Increase Kinarus Therapeutics Holding AG publishes FY2023 Financial Statements and announces details ...
01.03.24 - DGAP
Extraordinary General Meeting of Kinarus Holding approved all resolutions relating to the envisaged Business Combination with Curatis
Kinarus Therapeutics Holding AG / Key word(s): AGMEGM Extraordinary General Meeting of Kinarus Holding approved all resolutions relating to the envisaged Business ...
28.02.24 - DGAP
Publication of unaudited financial statements of Kinarus Therapeutics Holding AG (only) for FY2023
Kinarus Therapeutics Holding AG / Key word(s): Annual Results Publication of unaudited financial statements of Kinarus Therapeutics Holding AG (only) for FY2023 28-Feb-2024 / ...
06.02.24 - DGAP
Courts of Basel-Stadt have revoked bankruptcy of Kinarus Therapeutics Holding AG
Kinarus Therapeutics Holding AG / Key word(s): Acquisition/Insolvency Courts of Basel-​Stadt have revoked bankruptcy of Kinarus Therapeutics Holding AG 06-Feb-2024 / 07:10 ...
29.01.24 - DGAP
Kinarus Therapeutics Holding AG in Liquidation and Curatis AG propose to combine companies and reverse bankruptcy procedures of Kinarus Therapeutics Holding AG in Liquidation
Kinarus Therapeutics Holding AG / Key word(s): Acquisition/Capital Increase Kinarus Therapeutics Holding AG in Liquidation and Curatis AG propose to combine companies and ...
25.09.23 - DGAP
Kinarus Therapeutics has decided to file for bankruptcy
Kinarus Therapeutics Holding AG / Key word(s): Insolvency Kinarus Therapeutics has decided to file for bankruptcy 25-Sep-2023 / 07:00 CET/CEST Release of an ad hoc ...
30.08.23 - DGAP
Kinarus Therapeutics Group Reports First Half 2023 Financial Results
Kinarus Therapeutics Holding AG / Key word(s): Half Year Results Kinarus Therapeutics Group Reports First Half 2023 Financial Results 30-Aug-2023 / 18:00 CET/CEST Release ...
25.08.23 - DGAP
Kinarus Therapeutics signed licensing agreement to extend cash for operations
Kinarus Therapeutics Holding AG / Key word(s): Funds/Partnership Kinarus Therapeutics signed licensing agreement to extend cash for operations 25-Aug-2023 / 18:00 CET/CEST ...
12.07.23 - DGAP
Kinarus Therapeutics Announces Personnel Changes
Kinarus Therapeutics Holding AG / Key word(s): Personnel Kinarus Therapeutics Announces Personnel Changes 12.07.2023 / 07:00 CET/CEST
12.07.23 - GlobeNewswire
Kinarus Therapeutics Announces Personnel Change
Basel, Switzerland, July 12 , 2023 – Kinarus Therapeutics Holding AG (“Kinarus”) (SIX: KNRS), a clinical-​stage biopharmaceutical company developing novel therapeutics to treat viral, ...
29.06.23 - DGAP
Kinarus Therapeutics Shareholders Approve All Board Proposals at the 2023 Annual General Meeting
Kinarus Therapeutics Holding AG / Key word(s): AGMEGM Kinarus Therapeutics Shareholders Approve All Board Proposals at the 2023 Annual General Meeting 29.06.2023 / 18:00 ...
29.06.23 - GlobeNewswire
Kinarus Therapeutics Shareholders Approve All Board Proposals at the 2023 Annual General Meeting
Basel, Switzerland , 2 9 Jun e 202 3 . Kinarus Therapeutics Holding AG (SIX: KNRS) (“Kinarus” or the "Company"), a clinical-​stage biopharmaceutical company developing novel ...
27.06.23 - DGAP
Kinarus Therapeutics signed subordinated bridge loans to ensure further liquidity
Kinarus Therapeutics Holding AG / Key word(s): Financing Kinarus Therapeutics signed subordinated bridge loans to ensure further liquidity 27-Jun-2023 / 07:00 CET/CEST ...
27.06.23 - GlobeNewswire
Kinarus Therapeutics signed subordinated bridge loans to ensure further liquidity
Basel, Switzerland, June 26 , 2023 – Kinarus Therapeutics Holding AG (“Kinarus”) (SIX: KNRS), a clinical-​stage biopharmaceutical company developing novel therapeutics to treat viral, ...
02.06.23 - DGAP
Kinarus Therapeutics Publishes Invitation to the 2023 Annual General Meeting
Kinarus Therapeutics Holding AG / Key word(s): AGMEGM Kinarus Therapeutics Publishes Invitation to the 2023 Annual General Meeting 02.06.2023 / 08:00 CET/CEST
02.06.23 - GlobeNewswire
Kinarus Therapeutics Publishes Invitation to the 2023 Annual General Meeting
Basel, Switzerland , 2 Jun e 202 3 . Kinarus Therapeutics Holding AG (SIX: KNRS) (“Kinarus” or the "Company"), a clinical-​stage biopharmaceutical company developing novel ...
31.05.23 - DGAP
Kinarus Therapeutics Group Reports 2022 Annual Results
Kinarus Therapeutics Holding AG / Key word(s): Annual Results Kinarus Therapeutics Group Reports 2022 Annual Results 31-May-2023 / 07:00 CET/CEST Release of an ad hoc ...
31.05.23 - GlobeNewswire
Kinarus Therapeutics Group Reports 2022 Annual Results
Publishes Annual Report with Audited Consolidated Financial Results for Year Ended 31 December 2022 Clinical efforts re-​focused on developing KIN001 for original indications ...
11.05.23 - DGAP
Kinarus Therapeutics signed CHF1.5 million convertible loan agreement with ChaoDian (Hangzhou) Investment Management
Kinarus Therapeutics Holding AG / Key word(s): Financing Kinarus Therapeutics signed CHF1.5 million convertible loan agreement with ChaoDian (Hangzhou) Investment ...

Newssuche

Videos

newspaper
17.05.24 +6,63%
Technical Trading: Gold Long-​Chance
Gold Long Typ: Turbo Open End WKN: VD1G7Y Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »